There are effective alternatives to CPAP for some people with obstructive sleep apnea (OSA), but there is no single replacement that fits everyone. The right plan depends on whether the diagnosis is truly obstructive, how severe it is, how low oxygen falls, whether events depend on sleep position, where the airway collapses, other health conditions, and why CPAP is not working for you.
A custom oral appliance may suit one person. Another may need positional therapy, weight-management treatment, upper-airway surgery, or an implanted nerve stimulator. Some people get the best control from a combination. The goal is not to find the least medical-looking option. It is to find a treatment you can use that objectively controls the breathing problem.
Do not stop prescribed PAP while shopping for an alternative. Ask the sleep clinician how to maintain treatment until another option has been selected, adjusted, and confirmed with follow-up testing.
First, make sure this is obstructive sleep apnea
This guide is about OSA, in which the upper airway narrows or closes during sleep. Central sleep apnea is different: breathing effort repeatedly decreases because the brain's breathing signal is unstable. Mixed or treatment-emergent central events can also appear on a sleep study or PAP report.
Oxygen, adaptive servo-ventilation (ASV), and bilevel devices with a backup rate may be used for particular central or cardiopulmonary disorders. They are not general substitutes for CPAP in uncomplicated OSA. If a report mentions central or mixed apneas, get a sleep-medicine review before choosing from the options below.
Before replacing CPAP, identify why it is failing
CPAP can be highly effective when it is worn and the pressure reaches the airway. A mask problem, untreated nasal obstruction, an unsuitable pressure range, insomnia, or aerophagia can make an effective therapy feel impossible. A troubleshooting visit may solve the specific problem faster than starting over.
Ask the clinic or equipment team to review:
- Mask fit and leak: A different size, cushion, nasal-pillow, nasal, or full-face interface may change comfort and control.
- Dryness or congestion: Heated humidification, temperature adjustments, and treatment of nasal symptoms may help.
- Pressure discomfort: Ramp, expiratory pressure relief, pressure retitration, or a different PAP mode may be appropriate.
- Air swallowing: Mask leak, pressure, body position, and reflux symptoms may need review. Do not lower treatment pressure on your own.
- Claustrophobia or insomnia: Daytime mask practice, gradual desensitization, and direct treatment of insomnia or anxiety can make PAP usable.
- Residual events: Usage hours, leak, event type, and residual AHI can show whether the issue is nonuse, equipment, settings, or a different breathing disorder.
The American Academy of Sleep Medicine (AASM) recommends education, behavioral support, troubleshooting, and appropriate follow-up during PAP treatment 1. A rushed first setup is not proof that every PAP configuration will fail.
APAP and bilevel PAP are still PAP
Auto-adjusting PAP (APAP) changes pressure within a prescribed range. Bilevel PAP (BPAP) supplies a higher pressure while breathing in and a lower pressure while breathing out. These can address selected comfort or clinical needs, but they still use pressurized air and a mask.
The AASM recommends CPAP or APAP over routine BPAP for most adults with OSA. BPAP may still be chosen when pressure needs, intolerance, hypoventilation, or another condition warrants it 1. This is a clinical mode decision, not a reason to buy and configure a bilevel device yourself.
What should guide the alternative?
A useful treatment discussion starts with the original sleep study and a physical and dental assessment, not a catalog.
OSA severity and oxygen burden
Mild, moderate, and severe categories are based largely on the apnea-hypopnea index (AHI), but the number is not the whole risk picture. Oxygen drops, severe daytime sleepiness, driving risk, arrhythmia, heart or lung disease, stroke history, and resistant hypertension can make prompt, reliably effective control especially important.
A slower treatment such as weight loss or muscle exercises may be a useful adjunct, but it may not be a safe stand-alone bridge for someone with severe hypoxemia or dangerous sleepiness.
The pattern of obstruction
Review whether events occur mainly:
- while sleeping on the back
- during REM sleep
- at every position and sleep stage
- behind the soft palate, tonsils, tongue, or jaws
- with nasal obstruction that prevents comfortable PAP use
Drug-induced sleep endoscopy may be used before certain surgeries or hypoglossal nerve stimulation. It shows how the airway behaves during medication-induced sleep, but it does not replace the diagnostic sleep study.
Health, anatomy, and preferences
Teeth, gum health, jaw joints, tonsil size, nasal airflow, jaw position, body weight, prior operations, medication risks, and willingness to use or maintain a device all change the tradeoffs. Insurance criteria may be narrower than an FDA indication.
Custom oral appliance therapy
A mandibular advancement device holds the lower jaw forward to make the airway less collapsible. It is a well-established alternative for adults who cannot tolerate CPAP or who prefer another therapy.
The recommended device is custom-made and titratable, meaning a qualified dentist fits it and advances it gradually. A boil-and-bite mouthguard or generic anti-snoring tray is not equivalent. AASM and American Academy of Dental Sleep Medicine guidance favors a custom, titratable appliance over a noncustom device 2.
Oral appliances can reduce AHI, snoring, and sleepiness, but CPAP is generally more likely to normalize breathing and oxygen measures, especially as OSA becomes more severe. That does not rule out an appliance for severe OSA when PAP is intolerable. It makes careful titration and objective confirmation more important 2.
Common issues include jaw discomfort, excess saliva or dry mouth, tooth movement, and gradual bite changes. The treating dentist should monitor fit, gum and tooth health, jaw symptoms, and occlusion. The sleep clinician should arrange a follow-up sleep study with the appliance in place rather than judging success from quieter snoring alone 2.
Positional therapy
Positional therapy keeps a person from sleeping on their back. It can use a vibration trainer, belt, backpack-style device, or another structured method. It is most logical when the diagnostic study shows that AHI is substantially lower off the back.
A Cochrane review found that positional therapy improved AHI compared with no positional treatment, but CPAP reduced AHI more. The studies were small and generally short, so long-term effectiveness and nightly use remain less certain 3.
A special pillow may feel comfortable without reliably keeping you in the tested position. If positional therapy becomes the main treatment, confirm its effect with a home sleep apnea test or polysomnogram that records body position. It may also be combined with an oral appliance or PAP.
Weight-management treatment
Weight is not the cause of every case of OSA, and people in smaller bodies can have severe disease. When overweight or obesity contributes, however, weight reduction can make the airway less collapsible and reduce OSA severity.
The American Thoracic Society recommends a comprehensive lifestyle program for adults with OSA who are overweight or have obesity, with nutrition, physical activity, and behavioral support tailored to the person. Medication or bariatric surgery may be added when clinically appropriate 4.
Weight management should run alongside effective OSA treatment until repeat testing shows what has changed. A smaller neck, less snoring, or a lower scale number does not establish that apnea has resolved.
Tirzepatide is a medication, not a breathing device
In December 2024, the FDA approved tirzepatide (Zepbound) for moderate-to-severe OSA in adults with obesity, together with a reduced-calorie diet and increased physical activity 5. The approval was based on two 52-week randomized trials: one enrolled people not using PAP, and the other enrolled people who continued PAP.
In both trials, tirzepatide reduced AHI, body weight, and hypoxic burden more than placebo, but responses varied and not every participant reached remission 6. It is not indicated as an OSA treatment for every body size, and its adverse effects, contraindications, cost, and need for longer-term weight management belong in a prescribing discussion.
Do not stop PAP because a weight-management medicine has started. Arrange follow-up testing after a clinically meaningful change so the sleep clinician can decide whether treatment still needs adjustment.
Bariatric surgery
Bariatric surgery may substantially reduce OSA severity in eligible people, but residual OSA is common enough that it should not be called an automatic cure. The AASM recommends discussing bariatric-surgery referral with adults who have OSA, a BMI of 35 or higher, and cannot accept or tolerate PAP 7.
Referral is an evaluation, not a commitment to surgery. Eligibility, operative risk, nutrition follow-up, weight trajectory, and other obesity-related conditions all matter. PAP or another effective treatment generally remains necessary until repeat testing shows otherwise.
Upper-airway surgery
Surgery is not one procedure. The surgeon may address the nose, tonsils, palate, tongue base, jaws, or several levels, depending on the obstruction. Outcomes and recovery differ substantially.
AASM guidance recommends that clinicians discuss referral to a sleep surgeon with adults who have OSA, a BMI below 40, and cannot accept or tolerate PAP. It also supports discussing referral when pressure-related side effects prevent adequate PAP use 7. These thresholds guide the referral conversation. The guideline notes that a BMI of 40 or higher does not prevent an individualized referral discussion, and no referral threshold guarantees that surgery is suitable, effective, or covered.
Even when a large tonsil or another major airway abnormality is visible, the AASM generally suggests trying PAP first unless there is another surgical indication, such as chronic tonsillitis, a lesion, or a jaw problem that independently needs correction 7.
Nasal procedures
Septoplasty, turbinate reduction, nasal-valve repair, or sinus surgery may help when structural nasal blockage or chronic nasal disease interferes with breathing. Isolated nasal surgery often improves nasal symptoms and may reduce the PAP pressure needed, but systematic reviews do not show a consistent, clinically meaningful AHI reduction when it is used alone 8.
This makes nasal surgery more often a way to improve airflow and PAP tolerance than a universal stand-alone OSA operation.
Tonsil, palate, and tongue-base procedures
Tonsillectomy can be effective in selected adults with substantially enlarged tonsils. Palatal procedures, including forms of uvulopalatopharyngoplasty, reshape tissue behind the roof of the mouth. Tongue-base procedures address obstruction lower in the throat. Multilevel surgery may combine targets.
Selection matters because removing or reshaping tissue at the wrong level will not address collapse elsewhere. The AASM evidence review found improvements after upper-airway surgery overall, but the evidence combined varied operations and was often observational 9. Ask what the examination or sleep endoscopy shows, what success means for the proposed procedure, and how often additional treatment remains necessary.
Maxillomandibular advancement
Maxillomandibular advancement moves both the upper and lower jaws forward, enlarging the airway behind the palate and tongue. It may be considered for a recessed jaw, certain bite or skeletal patterns, or multilevel collapse, including in some people with severe OSA.
Systematic reviews show large average AHI reductions, but most included evidence comes from surgical cohorts rather than randomized trials 10. It is a major operation with orthodontic planning, recovery, and possible changes in bite, facial sensation, and appearance. A strong average result does not guarantee an individual cure.
Hypoglossal nerve stimulation
Hypoglossal nerve stimulation uses an implanted system to sense breathing and stimulate a nerve that moves the tongue, helping keep the airway open. It is an option for a selected group with moderate-to-severe, predominantly obstructive apnea who cannot use PAP.
For the Inspire system, the FDA-approved adult indication includes people age 22 or older with an AHI from 15 through 100 who cannot use or tolerate PAP and do not have complete concentric collapse at the soft palate. In 2023, the FDA expanded the upper AHI limit from 65 to 100 and the recommended upper BMI limit from 32 to 40 11.
Those numbers are not universal access criteria. A current CMS local coverage determination, for example, uses a BMI below 35, AHI from 15 through 65, fewer than 25% central or mixed events, recent sleep testing, documented CPAP failure or intolerance, and absence of complete concentric palatal collapse 12. Other insurers and devices may use different rules.
Evaluation typically includes a current sleep study, airway examination, and drug-induced sleep endoscopy. Limitations include implant surgery, healing, activation and programming visits, nightly use of a remote, stimulation discomfort, possible tongue weakness or abrasion, battery replacement, device interactions, and MRI conditions. Some people improve substantially, some retain residual OSA, and some do not meet response criteria 11.
Other prescription devices
Nasal expiratory positive airway pressure (EPAP) devices cover the nostrils and create resistance during exhalation. They do not use a powered CPAP machine. An older systematic review found average improvement in AHI and oxygen measures, but response varied and researchers could not identify a reliable responder profile 13.
Product availability and approved indications change, and evidence for one design does not automatically transfer to a current product. If a clinician recommends nasal EPAP, verify that the exact device is currently cleared and confirm effectiveness with sleep testing.
Supplemental oxygen can raise oxygen saturation in selected conditions, but it does not splint open an obstructed throat. It should not be used as a do-it-yourself CPAP replacement.
Helpful adjuncts are not universal replacements
Regular activity, limiting alcohol near bedtime, not smoking, treating nasal symptoms, and maintaining a stable sleep schedule can support OSA care 14. These measures may reduce a contributor or make another treatment easier to use, but they do not prove that airway obstruction is controlled.
Mouth and throat exercises
Myofunctional therapy uses a defined program of tongue, palate, facial, and breathing exercises. A Cochrane review found possible improvements in sleepiness and sleep quality, but certainty ranged from moderate to very low across comparisons, with small studies and limited long-term evidence 15.
A supervised program may be a reasonable adjunct for a selected person. A social-media exercise list is not a dependable replacement for PAP, an oral appliance, or surgery in moderate-to-severe OSA.
Mouth taping, supplements, and anti-snoring products
Mouth taping does not advance the jaw or reliably prevent throat collapse. A 2025 systematic review found limited evidence of benefit and identified safety concerns when nasal obstruction or regurgitation is present 16.
No herb or supplement has been shown to reliably splint an obstructed airway. Some products can also interact with medicines, so check them with a clinician or pharmacist. Nasal strips may help nasal airflow or snoring without treating collapse behind the palate or tongue. Unprescribed retail mouthguards, chin straps, pillows, rings, and anti-snoring electronics should not be assumed to treat diagnosed OSA because they make snoring quieter or improve a wearable score.
Every non-PAP treatment needs objective follow-up
Less snoring, fewer witnessed pauses, and more daytime energy are encouraging, but they cannot show the residual AHI or oxygen pattern. The AASM recommends follow-up polysomnography or a home sleep apnea test to assess response to non-PAP treatment 17.
Follow-up testing is especially relevant after:
- oral-appliance titration
- starting positional therapy as the main treatment
- upper-airway or bariatric surgery
- hypoglossal nerve stimulation programming
- substantial weight loss or gain
- a return of snoring, gasping, morning headaches, or daytime sleepiness
The result may show full control, partial improvement that needs combination therapy, or inadequate response. A person might use an oral appliance plus positional therapy, undergo nasal surgery to make PAP tolerable, or use a lower PAP pressure after another intervention. Needing a combination is not a treatment failure.
Questions to bring to the appointment
Ask the sleep clinician:
- Is my apnea entirely obstructive, and how severe are the oxygen drops?
- Is it position-dependent?
- What do my PAP usage, leak, pressure, and event data show?
- Has mask fitting, humidification, nasal treatment, desensitization, and pressure review been tried?
- Am I a candidate for a custom oral appliance, and who will confirm its effect?
- Does my anatomy justify an ENT or jaw-surgery consultation?
- If weight treatment is relevant, what should I use while it takes effect?
- Do I meet the current device label and my insurer's criteria for nerve stimulation?
- When and how will the alternative be tested?
If sleepiness makes driving unsafe, say so at the start of the visit. Avoid driving while sleepy and ask for a plan that does not leave severe OSA untreated during a long evaluation 18.
The bottom line
CPAP alternatives are chosen, not ranked. A custom titratable oral appliance, positional therapy, weight-management treatment, an anatomy-directed operation, or hypoglossal nerve stimulation may be appropriate after the diagnosis, severity, airway pattern, and reason for PAP difficulty are clear.
APAP and bilevel PAP are PAP modes, while ASV and oxygen belong to selected breathing disorders rather than routine OSA substitution. Retail snoring devices, mouth taping, supplements, and unsupervised exercises cannot be assumed to control OSA. Keep current treatment in place while a new plan is developed, and confirm every non-PAP treatment with an appropriate follow-up sleep study.
